Polycystic Kidney, Autosomal Dominant - 25 Studies Found Recruiting : Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease) : Autosomal Dominant Polycystic Kidney Disease (ADPKD) : 2016-09-15 : Drug: Tolvaptan Recruiting : Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) : Autosomal Dominant Polycystic Kidney Disease (ADPKD) : 2014-04-14 : Drug: Triptolide-Containing Formulation Completed : Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease : Autosomal Dominant Polycystic Kidney Disease (ADPKD) : 2011-07-29 Completed : A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan] : Autosomal Dominant Polycystic Kidney Disease (ADPKD) : 2010-12-06 : Drug: tolvaptan Repeated oral administration twice daily (morning and evening) at one of three split dos Active, not recruiting : Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency : Autosomal Dominant Polycystic Kidney Disease : 2011-06-20 : Drug: Octreotide-LAR 40 mg eve <<< Previous